H.R. 5623 · 117th Congress
The Insulin Cost Reduction Act
- Stage
- In committee
- Sponsor
- Glenn Grothman
- Introduced
- 2021-10-19
- Latest action
- 2021-10-20 · Referred to the Subcommittee on Health.
Summary
The Insulin Cost Reduction Act
This bill prohibits the negotiation of price concessions between insulin manufacturers and prescription drug plans under the Medicare prescription drug benefit unless the price concessions are either provided at the point of sale to beneficiaries or are reflected in cost-sharing requirements.